Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid for Recurrent Implantation Failure and Miscarriage
NCT01679561Phase 4Withdrawn
- Sponsor
- Woman's Health University Hospital
- Start
- Feb 2012
- Primary completion
- Aug 2012
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Intralipid 10% in Recurrent Implantation Failure (RIF), recurrent miscarriage (RPL), sponsored by Woman's Health University Hospital. Planned start Feb 2012; status: withdrawn.
02
Drugs
Intralipid 10%
03
Conditions
Recurrent Implantation Failure (RIF)recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT01679561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01679561.